BPC-157 the Body Protection Compound BPC-157 is a synthetic 15-amino-acid peptide derived from human gastric proteins
The company is leading with SJN314, an oral candidate it is developing for chronic urticaria, and with two ADC platform brands -- Oncoflame and Oncostarve -- as it looks for licensing and co-development partners
Related Reading Genetic Testing 101 What You Need To Know Before Getting Tested What Genetic Factors Determine How Much Sleep You Need Each Night Ro Wegovy Mochi Wegovy Pricing and availability current as of June 2026
BioMed Res Int (2015) 2015:652738
We also consider the potential for further reductions in mortality and morbidity as the therapeutic landscape for incretin-based drugs expands beyond obesity and diabetes
Currently, it appears that TB4 and TB-500 are best suited for adults with: Troublesome injuries or wounds (including those that are slow to heal) Inflammation Chronic pain due to inflammation Health issues involving the heart, liver, or eyes But its essential to remember that the research on these peptides is still in the early stages, and there have been only a handful of human trials